胸骨切开术后连续前锯肌平面阻滞镇痛:单中心可行性研究
该双盲试验评估双侧前锯肌平面导管用于心脏手术胸骨切开镇痛的大型试验可行性。52例随机,50例有可行性数据。因招募率低(2.4例/月)和气胸率12%,单中心判定不可行。罗哌卡因组与安慰剂组在疼痛、阿片消耗和恢复质量上无差异。
要点
- 单中心招募率仅2.4例/月,低于预设4例/月可行性阈值。
- 气胸发生率12%,高于预设≤2%的安全阈值。
- 罗哌卡因与安慰剂在疼痛、阿片消耗和QoR-15上无差异。
核心结论
- 单中心开展该大型试验不可行,主要因招募率低和气胸发生率高。
- 有限数据显示双侧前锯肌平面导管罗哌卡因镇痛对恢复质量无差异。
研究设计与样本
- 双盲随机对照可行性试验,纳入心脏手术胸骨切开患者。
- 所有参与者置入双侧前锯肌平面导管,随机接受罗哌卡因或安慰剂。
- 52例随机,50例有可行性数据。
主要发现
- 招募率2.4例/月,低于预设>4例/月。
- 气胸率12%,高于预设≤2%。
- 方案依从率>90%,主要结局测量率>90%,无重大方案偏离,12%参与者有轻微偏离。
- 疼痛、阿片消耗、并发症和恢复质量组间无差异。
- 两组3个月长期疼痛均低。
关键数值与推荐
- 可行性预设终点:招募率>4例/月,方案依从率>90%,主要结局测量率>90%,导管相关严重不良事件率≤2%。
- 实际招募率2.4例/月,气胸率12%,判定不可行。
临床怎么用
- 该单中心结果不支持将双侧前锯肌平面导管作为胸骨切开术后常规镇痛方案推广。
- 开展类似试验需考虑多中心合作以提高招募率并评估气胸风险。
局限性
- 单中心可行性研究,样本量有限。
- 有限数据下恢复质量比较可能不充分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Moderate-to-severe pain is common after cardiac surgery, peaking during the first and second postoperative days. Several nerve blocks for sternotomy have been described; however, the optimal location for continuous catheters has not been established. This study assessed the feasibility of a larger trial evaluating the efficacy of serratus anterior plane (SAP) catheter analgesia for sternotomy pain. METHODS: This double-blinded trial included patients undergoing cardiac surgery via sternotomy. Bilateral SAP catheters were placed in all participants, and randomised to ropivacaine or placebo. We assessed feasibility based on predetermined endpoints: (1) average recruitment rate >4 per month; (2) protocol adherence rate >90%; (3) primary outcome measurement rate >90%; and (4) significant catheter-related adverse event rate ≤2%. The quality of recovery index (QoR-15) was compared using an independent t-test. RESULTS: Of 52 participants randomised, feasibility data were available for 50. A definitive study was deemed 'not feasible' in our standalone centre owing to a low recruitment rate (2.4 per month) and a high adverse event rate (pneumothorax rate 12%). There were no major protocol deviations but minor deviations in 12% of participants. Pain, opioid consumption, complications, and quality of recovery were not different between groups. Long-term pain at 3 months was low in both groups. CONCLUSIONS: A single-centre trial was deemed not feasible for our setting. With limited data, the quality of recovery was not different with ropivacaine dosing of bilateral SAP catheters for sternotomy pain. CLINICAL TRIAL REGISTRATION: NCT04648774.
引用
- Bailey JG, Hendy A, Neira V, et al. Continuous serratus anterior block for sternotomy analgesia after cardiac surgery: a single-centre feasibility study. Br J Anaesth. 2025. PMID: 39863465. doi:10.1016/j.bja.2024.11.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。